Multi-scale Computational Models of Pro-angiogenic Treatments in Peripheral Arterial Disease
Open Access
- 10 April 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Biomedical Engineering
- Vol. 35 (6), 982-994
- https://doi.org/10.1007/s10439-007-9303-0
Abstract
The induction of angiogenesis is a promising therapeutic strategy for the amelioration of peripheral arterial disease (PAD). This occlusive disease results in muscle ischemia, and neovascularization is a route to increasing the perfusion in the tissue. The vascular endothelial growth factor (VEGF) family of potent pro-angiogenic cytokines is a potential therapeutic agent, increasing VEGF-receptor signaling on tissue vasculature. To investigate the effects of possible therapies on the VEGF concentrations and gradients within the tissue, we consider three such strategies: VEGF gene therapy (e.g. by adeno-associated virus); VEGF cell-based therapy (injected myoblasts that overexpress VEGF); and chronic exercise (which upregulates VEGF receptor expression). The multi-scale computational model used to investigate these strategies is an integration of several components: an anatomical description of the muscle geometry and cell types; microvascular blood flow; tissue oxygen distribution; VEGF secretion from muscle fibers; VEGF transport through interstitial space; and VEGF-receptor binding on microvascular endothelial cells. Exercise training, which results in increased VEGF secretion in hypoxic tissue and increased VEGF receptor expression, exhibits increases in both VEGF concentration and VEGF gradients, and is predicted to be more effective than the other, VEGF-only treatments.Keywords
This publication has 62 references indexed in Scilit:
- Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exerciseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Dimerization of VEGF receptors and implications for signal transduction: A computational studyBiophysical Chemistry, 2007
- Computational Model of Vascular Endothelial Growth Factor Spatial Distribution in Muscle and Pro-Angiogenic Cell TherapyPLoS Computational Biology, 2006
- A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1αJournal of Cell Science, 2006
- A computational model of oxygen transport in skeletal muscle for sprouting and splitting modes of angiogenesisJournal of Theoretical Biology, 2006
- Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesisExperimental Cell Research, 2006
- Engineered Zinc Finger–Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb IschemiaCirculation, 2004
- Collateral Artery Growth (Arteriogenesis) After Experimental Arterial Occlusion Is Impaired in Mice Lacking CC-Chemokine Receptor-2Circulation Research, 2004
- Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trialAmerican Heart Journal, 2003
- VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor bindingJournal of Cellular Biochemistry, 2002